A generic version of Narcan, a device for ADHD & more: 6 recent FDA approvals

Six drugs or medical devices have been approved by the FDA since April 12:

1. The first generic version of Narcan, a naloxone nasal spray used to reverse opioid overdoses

2. The Current wireless wearable, a  smartphone-sized device secured to a users' upper arm, measures patients' vital signs in real time.

3. The KardiaMobile electrocardiogram, a smartphone-compatible consumer device, detects three types of heart arrhythmias, including bradycardia, tachycardia and atrial fibrillation.

4. The Monarch external trigeminal nerve stimulation system is the first digital medical device to treat ADHD in children.

5. Balversa is a treatment for adult patients with advanced metastatic bladder cancer that has genetic alterations known as fibroblast growth factor receptors.

6. Skyrizi, a subcutaneous injection, treats moderate to severe plaque psoriasis in adults who are eligible for phototherapy or systemic therapy. It is manufactured by AbbVie.

More articles on supply chain:
3 burglars steal $450K worth of colonoscopes from Pennsylvania hospital
6 things to know about WakeMed's drone delivery program
Mislabeled fentanyl patches recalled

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months